Open AccessIs Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2?
Author(s) -
Bilger Çavuş,
Filiz Akyüz,
Asi Omerci Cifcibasi,
İlker Özgür,
Cansu Erel,
Aysun Yakut,
Ziya Imanov,
İbrahim Volkan Şenkal,
Alpay Medetalibeyoğlu,
Murat Köse,
Metin Keskin,
Kadir Demır,
Fatih Beşışık,
Sabahattin Kaymakoğlu
Publication year - 2022
Publication title -
the turkish journal of gastroenterology : the official journal of turkish society of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 2148-5607
DOI - 10.5152/tjg.2022.211113
Subject(s) - medicine , inflammatory bowel disease , coronavirus , gastroenterology , mesalazine , abdominal pain , disease , diarrhea , azathioprine , nausea , covid-19 , infectious disease (medical specialty)
The severe acute respiratory syndrome coronavirus 2 virus was found to have effects not only in the lungs but also in many different organs. We aimed to evaluate the management of our patients with inflammatory bowel disease in this pandemic, the incidence of coronavirus disease 2019 in terms of clinical, medical treatment, and features of inflammatory bowel disease, and to investigate the effects of the severe acute respiratory syndrome coronavirus 2 on this particular group of patients.